Injectable B12 bypasses the digestive tract, ensuring superior absorption compared to oral supplements
It combines three well-studied peptidesGHK-Cu, BPC-157, and TB500into a single laboratory-grade blend designed for controlled experimental applications
Although research on intranasal administration of BPC-157 is extremely limited, broad studies on the potential benefits of intranasally administered peptide therapeutics suggest that this may be a beneficial RoA [11, 12]
Available in 10mg, 15mg, 20mg, and 30mg vials
BPC-157 is a pentadecapeptide of 15 amino acids, derived from a protective protein found naturally in human gastric juice
The NHS guidance on vitamin B12 deficiency treatment recommends a loading course of injections first, followed by regular maintenance doses